Tofacitinib for refractory ocular mucous membrane pemphigoid

PURPOSE: To report the successful use of tofacitinib in the treatment of refractory ocular mucous membrane pemphigoid (MMP). OBSERVATIONS: Two patients with ocular MMP presented with refractory disease after failure of multiple therapies. Treatment with tofacitinib led to durable control of conjunct...

Full description

Saved in:
Bibliographic Details
Published in:Am J Ophthalmol Case Rep
Main Authors: James, Hayley, Paley, Grace L., Brasington, Richard, Custer, Philip L., Margolis, Todd P., Paley, Michael A.
Format: Artigo
Language:Inglês
Published: Elsevier 2021
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8111584/
https://ncbi.nlm.nih.gov/pubmed/34007952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2021.101104
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items